MiNK Therapeutics Inc. (INKT:NASDAQ) soared at $3, representing a gain of 35.7%. On Fri, Nov 11, 2022, INKT:NASDAQ hit a New 2-Week High of $3. The stock appeared on our News Catalysts scanner on Thu, Nov 10, 2022 at 11:26 AM in the 'BIOTECH' category. From Mon, Oct 31, 2022, the stock recorded 55.56% Up Days and 70.00% Green Days
The stock spiked on Wed, Aug 17, 2022 at $4.32 with a volume of 1M+.
About MiNK Therapeutics Inc. (INKT:NASDAQ)
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other life-threatening...
Top 10 Gainers:
- Renovare Environmental Inc. (RENO:NASDAQ), 60%
- ShiftPixy, Inc. (PIXY:NASDAQ), 56.56%
- Exela Technologies, Inc. (XELA:NASDAQ), 50.27%
- uCloudlink Group Inc. (UCL:NASDAQ), 49.61%
- Core Scientific Inc Cl A (CORZ:NASDAQ), 44.28%
- Compass Inc. Class A (COMP:NYSE), 44.03%
- Quanergy Systems Inc. (QNGY:NYSE), 42.75%
- Kaleyra Inc. (KLR:NYSE), 38.46%
- Nutex Health Inc. (NUTX:NASDAQ), 37.67%
- MiNK Therapeutics Inc. (INKT:NASDAQ), 35.75%